GPP
ADMS
Great Point Partners’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-256,340
| Closed | -$5.43M | – | 47 |
|
|
2017
Q3 | $5.43M | Sell |
256,340
-1,960,011
| -88% | -$41.5M | 1.06% | 22 |
|
|
2017
Q2 | $38.8M | Sell |
2,216,351
-385,000
| -15% | -$6.73M | 6.94% | 2 |
|
|
2017
Q1 | $45.5M | Hold |
2,601,351
| – | – | 9.04% | 1 |
|
|
2016
Q4 | $44M | Hold |
2,601,351
| – | – | 9.03% | 1 |
|
|
2016
Q3 | $42.7M | Buy |
2,601,351
+492,252
| +23% | +$8.08M | 10.89% | 2 |
|
|
2016
Q2 | $31.9M | Hold |
2,109,099
| – | – | 9.14% | 1 |
|
|
2016
Q1 | $30.5M | Buy |
2,109,099
+671,764
| +47% | +$9.71M | 10.94% | 1 |
|
|
2015
Q4 | $40.7M | Buy |
1,437,335
+327,335
| +29% | +$9.27M | 17.08% | 1 |
|
|
2015
Q3 | $18.6M | Buy |
1,110,000
+337,400
| +44% | +$5.65M | 7.35% | 4 |
|
|
2015
Q2 | $20.3M | Buy |
772,600
+163,950
| +27% | +$4.3M | 7.9% | 2 |
|
|
2015
Q1 | $10.6M | Buy |
608,650
+437,834
| +256% | +$7.66M | 4.68% | 5 |
|
|
2014
Q4 | $2.97M | Buy |
+170,816
| New | +$2.97M | 1.43% | 19 |
|